Trial Information

Summary: A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving Chemotherapy.

Status: Completed

Protocol Number: NA17101

Sponsor: Hoffmann-La Roche Inc

Company Division: Pharmaceutical

Official Scientific Title: A randomized, open-label study of the effect of subcutaneous Mircera on hemoglobin level/correction in anemic patients with Stage IIIB or IV non-small-cell lung carcinoma receiving antineoplastic therapy

Brief Summary: This study will assess the efficacy and safety of different subcutaneous (sc) doses and dosing frequencies of Mircera in patients with non-small cell lung cancer (NSCLC) and anemia who are receiving chemotherapy. The anticipated time on study treatment is less than 3 months and the target sample size is 100-500 individuals. Target sample size is 210.

Study Phase: II

Study Design / Study Details:

• Purpose: Treatment
• Allocation: Randomized
• Masking: Open Label
• Control: Active
• Assignment: Parallel
• Endpoints: Safety/Efficacy

Study Type:

Condition: Anemia

Intervention Type: Drug

Intervention Name: methoxy polyethylene glycol-epoetin beta[Mircera]

Primary Outcome: 1. Efficacy:Time-adjusted average hemoglobin value between baseline and end of initial treatment

Key Secondary Outcomes: 1. Efficacy: Change from baseline in Hb, Hct, reticulocyte count, Hb and hematopoietic response, transfusion requirements Safety: Vital signs, AEs, lab values

Inclusion Criteria:

Exclusion Criteria:

Gender: Males or Females

Age Limits: Min: 18 Years

Accepts Healthy Volunteers: No

Trial Registration Date: 05/23/2005

Date Last Updated: 06/17/2008

Link To Trial Results

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 30, 2008 at 3:03:51 PM